Viridian Therapeutics
VRDN
VRDN
167 hedge funds and large institutions have $2.01B invested in Viridian Therapeutics in 2025 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 53 increasing their positions, 65 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
11% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 18
18% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 65
52% less call options, than puts
Call options by funds: $1.02M | Put options by funds: $2.14M
Holders
167
Holding in Top 10
12
Calls
$1.02M
Puts
$2.14M
Top Buyers
| 1 | +$21.9M | |
| 2 | +$18.4M | |
| 3 | +$14.9M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$11.9M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$7.25M |
Top Sellers
| 1 | -$36.1M | |
| 2 | -$12.3M | |
| 3 | -$10.3M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$7.31M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$4.84M |
